If you want to know how nervous the pharmaceutical industry is about the prospect of new federal regulation of compounding pharmacies — like the one involved in last year’s lethal fungal meningitis outbreak — look to K Street.
As lawmakers have introduced bills in the House and Senate to regulate these drug-making practices, pharmacies, pharmaceutical companies and trade groups are ramping up their lobbying support for the battle to come.
Read more: http://www.politico.com/story/2013/09/lobbyists-roll-up-sleeves-for-compounding-battle-97221.html#ixzz2foD1olIe